According to Hualan Biological Engineering's latest financial reports the company has $0.44 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.50 B | -4.4% |
2021-12-31 | $0.52 B | -14.75% |
2020-12-31 | $0.61 B | 27.87% |
2019-12-31 | $0.48 B | 34.86% |
2018-12-31 | $0.35 B | 1030.08% |
2017-12-31 | $31.66 M | -54.76% |
2016-12-31 | $69.99 M | 24.87% |
2015-12-31 | $56.05 M | -48.36% |
2014-12-31 | $0.10 B | -36.56% |
2013-12-31 | $0.17 B | 42.61% |
2012-12-31 | $0.11 B | -14.76% |
2011-12-31 | $0.14 B | -13.77% |
2010-12-31 | $0.16 B | 58.29% |
2009-12-31 | $0.10 B | 140.64% |
2008-12-31 | $42.85 M | 109.28% |
2007-12-31 | $20.47 M | -20.72% |
2006-12-31 | $25.82 M | 4.67% |
2005-12-31 | $24.67 M | -9.85% |
2004-12-31 | $27.36 M | 365.37% |
2003-12-31 | $5.88 M | 66.89% |
2002-12-31 | $3.52 M | 11.1% |
2001-12-31 | $3.17 M |